Johnson and Johnson is a perennial favorite among many investors because of its solid operating history and relative stability; however, it is not suitable for Defensive Investors because of the lack of sufficient earnings growth over the ten year historical period and the high PEmg and PB ratios.
Company Profile (obtained from Google Finance): Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, […]
The company of the week this week is Johnson & Johnson (JNJ), a manufacturer of a range of products in the healthcare field. As we did last week, we will be looking reviewing the company using Warren Buffett’s approach for the Business & Management Review. We will also use Benjamin Graham’s overall philosophies to guide […]